Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population

Renal Failure

Volumn 32, Issue 10, 2010, Pages 1172-1176

  Chen, Shih Yin ^a,b   Chen, Cheng Hsu ^a,b,c   Huang, Yu Chuen ^a,b   Chuang, Hsuan Min ^a   Lo, Ming Min ^d   Tsai, Fuu Jen ^a,e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHAOYANG UNIVERSITY OF TECHNOLOGY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Cytokine; Interleukin 6; Kidney disease; Membranous glomerulonephritis; Single nucleotide polymorphisms

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; GENE FREQUENCY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROEPIDEMIOLOGIC STUDIES; TAIWAN;

EID: 77958159787     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.516857     Document Type: Article

References (25)

1. Lewis EJ. Management of nephrotic syndrome in adults. In: Cameron JS, Glassock RJ, ed. The Nephrotic Syndrome. New York: Marcel Dekker; 1988:461-521.
2. Schieppati A, Mosconi L, Perna A, et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med. 1993;329:85-89.
3. Philibert D, Cattran D. Remission of proteinuria in primary glomerulonephritis: We know the goal but do we know the price? Nat Clin Pract Nephrol. 2008;4:550-559.
4. Lo WY, Chen SY, Wang HJ, et al. Association between genetic polymorphisms of the NPHS1 gene and membranous glomerulonephritis in the Taiwanese population. Clin Chim Acta. 2010;411:714-718.
5. Chen KH, Chang CT, Hung CC. Glomerulonephritis associated with chronic inflammatory demyelinating polyneuropathy. Ren Fail. 2006;28:255-259.
6. Yen TH, Huang JY, Chen CY. Unexpected IgA nephropathy during the treatment of a young woman with idiopathic dermatomyositis: Case report and review of the literature. J Nephrol. 2003;16:148-153.
7. Boswell JM, Yiu MA, Burt DW, Kelley VE. Increased tumour necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol. 1988;141:3050-3054.
8. Boswell JM, Yui MA, Endres S, et al. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J Immunol. 1988;141:118-124.
9. Noble B, Ren KI, Tavernes J, et al. Mononuclear cells in glomeruli and cytokines in urine reflect the severity of experimental proliferative immune complex glomerulonephritis. Clin Exp Immunol. 1990;80:281-287.
10. Horii Y, Muraguchi A, Iwano M, et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol. 1989;143:3449-3455.
11. Dohi K, Iwano M, Muraguchi A, et al. The prognostic significance of urinary interleukin 6 in IgA nephropathy. Clin Nephrol. 1991;35:1-5.
12. Gordon C, Richards N, Howie AJ, et al. Urinary IL-6: A marker for mesangial proliferative glomerulonephritis?. Clin Exp Immunol. 1991;86:145-149.
13. Chen CH, Shu KH, Wen MC, et al. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy. Nephrol Dial Transplant. 2008;23:3166-3173.
14. Ponticelli C, Zucchelli P, Imbasciati E, et al. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 1984;310:946-950.
15. Ehrenreich T, Porush JG, Churg J, et al. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976;295:741-746.
16. Wakai S, Magil AB. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int. 1992;41:428-434.
17. Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829-842.
18. Maisonneuve P, Agodoa L, Gellert R, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am J Kidney Dis. 2000;35:157-165.
19. Wehrmann M, Bohle A, Bogenschutz O, et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulointerstitial change. Clin Nephrol. 1989;31:67-76.
20. Jiménez A, Sánchez B, Pérez Alenza D, et al. Membranous glomerulonephritis in the Iberian lynx (Lynx pardinus). Vet Immunol Immunopathol. 2008;121:34-43.
21. Bantis C, Heering PJ, Aker S, et al. Tumor necrosis factor-alpha gene G-308a polymorphism is a risk factor for the development of membranous glomerulonephritis. Am J Nephrol. 2006;26:12-15.
22. Cattran DC. Idiopathic membranous glomerulonephritis. Kidney Int. 2001;59:1983-1994.
23. Stratta P, Bermond F, Guarrera S, et al. Interaction between gene polymorphisms of nitric oxide synthase and renin-angiotensin system in the progression of membranous glomerulonephritis. Nephrol Dial Transplant. 2004;19:587-595.
24. Smallwood L, Allcock R, van Bockxmeer F, et al. Polymorphisms of the interleukin-6 gene promoter and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2008;35:31-36.
25. Gu W, Du DY, Huang J, et al. Identification of interleukin-6 promoter polymorphisms in the Chinese Han population and their functional significance. Crit Care Med. 2008;36:1437-1443.